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Protective patient equipment for CT examinations is not routinely provided. The aim of this study was to determine whether,
and if so what, specific protective equipment is beneficial during CT scans. The absorbed organ doses and the effective doses
for thorax, abdomen/pelvis and brain CT investigation with and without the use of protective patient equipment have been
determined and compared. All measurements were carried out on modern multislice CT scanner using an anthropomorphic
phantom and thermoluminescence dosemeters. The measurements show that protective equipment reduces the dose within the
scattered beam area. The highest organ dose reduction was found in organs that protrude from the trunk like the testes or the
female breasts that can largely be covered by the protective equipment. The most reduction of the effective dose was found in
the male abdomen/pelvis examination (0.32 mSv), followed by the brain (0.11 mSv) and the thorax (0.06 mSv). It is con-
cluded that the use of protective equipment can reduce the applied dose to the patient.
INTRODUCTION
According to the Radiation Protection Ordinance of
20 January 1998(1), every X-ray facility in Switzerland
must have the necessary protective equipment. The
following equipment is the minimum required to
protect patients, staff and third parties:
(1) Full apron/coat apron,
(2) Demi apron,
(3) Testicular and ovarian shields,
(4) Covering materials.
Opinions diverge in certain areas of radiology on
whether this equipment should be used to protect
patients. In particular, their effectiveness in CT is
disputed.
The aim of this study was to determine the dosi-
metric data needed to evaluate whether, and if so
what, specific protective equipment is beneficial. The
results provide a basis for giving institutions appro-
priate advice on matters relating to CT audits.
MATERIALS AND METHODS
Phantom
All measurements were carried out on an anthropo-
morphic Alderson RANDO phantom, which con-
sists of a human skeleton embedded in plastic that
has equivalent radiological properties to human
tissues. The lungs are made of a plastic that matches
the density of human lungs in the mid-stage of inspi-
ration. The phantom represents the trunk of a
standard male patient, without arms or legs, 175 cm
tall and weighting 73.5 kg. It can be dismantled into
thirty-six 2.5 cm-thick sections numbered from 0 at
the cranial end to 35 at the caudal end (Figure 1).
The slices contain a grid of pre-drilled holes at inter-
vals of 1.51.5 cm into which thermoluminescence
dosemeters (TLDs) can be inserted.
The female breast measurements were recorded on
a breast phantom. This piece of equipment can be
attached to the male Alderson phantom level with
slices 15–18 using an adapter. The breast phantom
consists of 2.5 cm-thick plastic slices with holes
arranged at intervals of 22 cm.
Dosimetry
TLD100 thermoluminescence detectors made from
LiF and spiked with Mg and Ti were used for the
dose measurements. According to the manufacturer,
the TLD100 has a measuring range of between
10 mGy and 10 Gy. The square TLDs measure
3.23.20.9 mm and fit into the holes of the
above-mentioned phantom.
The TLDs were thermally prepared (annealed) in
a programmable oven before each exposure to radi-
ation. This involved heating the TLDs at 4008C for
60 min before cooling them to 1008C in a controlled
manner following a specified constant gradient. The
TLDs were then kept at this temperature for 120
min, after which the oven was switched off and the
TLDs were left to cool to room temperature.
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The TLDs were stored at room temperature for
12 h after each radiation exposure and then heated
again for 10 min to 1008C (pre-annealing) before
they were evaluated. They were then read out within
the following hours. A Harshaw-type 5500 TLD
automatic reader was used for this purpose.
The sensitivity factors of the individual TLDs
were determined with an Sr90/Y90 irradiator per-
forming 100 rotations. The measured results divided
by the mean of all evaluated TLDs were taken as a
reference value for the sensitivity of the individual
TLDs. This individual sensitivity was factored into
the dose calculation.
The radiation quality-dependent calibration
factors were determined on a radiotherapy unit at a
tube voltage of 125 kV and filtration of 2.5 mmAl þ
0.1 mmCu. This filtration closely approximates to
that of CT scanners. A Farmer chamber (PTW
Fribourg, TM30013) calibrated by the Institut
Universitaire de Radiophysique Applique´e (cali-
bration agency for radiation protection measuring
devices authorised by the Swiss Confederation)
served as the reference system. The calibration
measurements were carried out on a Perspex
phantom. The calibration factors were determined
within the primary beam field at depths of 0.7, 2.7,
5.7, 10.7 and 20.7 cm. Calibration in the scattered
beam area was carried out at a depth of 7 cm and at
intervals of 2.5, 5, 10 and 20 cm from the edge of
the primary beam. Reproducibility was between 3
and 5 %.
The glow curves resulting from the read-outs were
subjected to visual spot checks so as to rule out any
system errors in the evaluation.
In all evaluations, a number of TLDs that had not
been exposed to radiation were read in order to
determine background radiation. This was then
deducted from each of the measured results.
Protective equipment
The protective equipment listed in Table 1 was used
for the individual investigations. For the thorax inves-
tigation, the demi apron was wrapped around the
phantom’s trunk caudal to the primary beam and for
the abdomen/pelvis cranial to the primary beam. The
coat apron used for the brain investigation covered the
complete trunk of the phantom all around.
A gap between the primary beam window and the
protective equipment (edge of the lead) of 1 1/2 or
2 phantom slices (3.75 or 5 cm) was selected for the
thoracic investigations, a gap of 5 cm for the pelvic/
abdomen investigations and, for the brain investi-
gations, a gap of 3.75 cm between the field edge at
the level of the mastoid process and the upper edge
of the thyroid protector. The exact location of the
protection with respect to the slice numbers are
listed in Table 2.
The items of protective equipment used were
scanned manually for damage and breaks and exam-
ined visually with the aid of a CT scan to ensure
correct functioning.
CT scanners and investigations
The measurements were carried out on two different
Siemens CT scanners: a Siemens Somatom
Sensation Cardiac 64 (64 slices) and a Siemens
Somatom Sensation 16 (16 slices). Both are latest-
generation multislice spiral CT scanners.
The investigations were selected on the basis of
the list published(2), which lists the most frequent
CT investigations/issues for adults and the five most
frequent ones for children. The following three inves-
tigations were selected from this list in view of their
clinical relevance: Cranial/brain (no. 1), thorax
(vessels) (no. 9) and abdomen/pelvis (no. 13).
The thoracic, abdominal/pelvic and brain investi-
gations were all conducted on the 64-slice CT
scanner. A further thoracic investigation was carried
out with the 16-slice CT scanner.
In addition to a general overview scan (topo-
gram), several (5 or 10) series of tomographies were
recorded for each investigation. This procedure had
the advantage of accumulating higher doses at the
measuring sites, thereby increasing the measuring
accuracy. In addition, geometry-dependent phenom-
ena such as the start point of the X-ray tube were
also flattened. For the purpose of the analyses,
measurements were taken for each investigation with
and without protective equipment. All measurements
were taken at the same exposure settings.
Figure 1. Topogram of the Alderson phantom (without
head) with slice numbers.
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In order to obtain measurements that matched
practical conditions as closely as possible, the
exposure settings (Table 2) were derived from the
results of previous CT audits conducted and evalu-
ated by the Federal Office of Public Health. The
means of the recorded settings were used
Automatic tube current modulation
The automatic tube current modulation option
(known as ‘Care Dose’ on Siemens scanners) was
used for the first measurements (thoracic investi-
gation with 64-slice CT), in line with standard
practice. However, this resulted in a deviation of 8 %
in the effective tube current for the two investi-
gations with and without protective equipment (103
mAs without and 112 mAs with protective equip-
ment). The automatic tube current modulation was
switched off for the remaining measurements in
order to improve comparability. This is the standard
procedure in any case for brain investigations.
Measuring points
Within each phantom slice, the dose was measured
at the centre and at four peripheral measuring points
Table 1. Overview of protective equipment used.
Protective equipment Lead equivalent (mm) Thorax Abdomen/pelvis Brain
Wrap-around demi apron 0.5  
Coat apron 0.5 
Thyroid protector 0.5  
Testicular capsules 1 a
aFor technical reasons the testicular capsules were not used, but the results from ref. (7) were applied to the measured
results.
Table 2. Overview of investigations and exposure settings.
Investigation/settings
Thorax 64Sa Thorax 16S Abdomen/pelvis 64S Brain 64S
Tube voltage 120 kV 120 kV 120 kV 120 kV
Tube current 103/112b mAs 100 mAs 165 mAs 380 mAs
Pitch 1.15 1.15 1.15 —
Rotation time 0.5 s 0.5 s 0.5 s 1 s
Collimation 241.2 mm 161.5 mm 241.2 mm 241.2 mm
Tube current
modulation
Yes No No No
Series of
tomographies
5 10 10 10
CTDIvol 7.01/7.95 mGy 7 mGy 11.11 mGy 51.93 mGy
DLP 292/317 mGy cm 299 mGy cm 472 mGy cm 753 mGy cm
Recording length 37 cm 37 cm 37 cm 14 cm
Primary beam area Slice no.10–middle no. 24 Slice no.10–no. 24 Slice no. 20/23–no. 34c Slice no. 0–middle no. 5d
Position of protective
equipment
Slice no. 26–no. 35 Slice no. 27–no. 35 Slice no. 8–no. 17 Slice no. 8–no. 35
Gap between edge of
primary beam and
edge of protective
equipment
3.75 cm 5 cm 5 cm 1.25–7.5 cme
aRefers to the number of slices (64S or 16S) of the scanner type.
bDiffering effective mAs for the investigations with and without protective equipment are caused by the tube current
modulation. This also results in the differing CTDIvol and DLP figures.
cA separate measurement of the female breast was carried out with the same exposure settings. However, the recording
window only extended from slice nos. 23–34. This allowed a gap of 5 cm to be maintained between the lower breast line
and the edge of the primary beam, and the breast was completely covered by the protective equipment.
dWith 11.58 inclination.
eDiffering gaps because the doses were recorded with an inclined gantry.
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(two ventral and two dorsal; Figure 2). Wherever
possible the measuring points were selected along
the body axis (z-axis) at the same position in all
slices.
A deviation from this procedure was made for
certain specific slices, e.g. at the level of the thyroid.
Since few holes were available, representative
measuring points were selected within the relevant
organs. Where slices contained organs of special
interest, e.g. at the ovary level, additional points
were measured within these organs. To measure the
dose received by the testes, four TLDs were placed
on the inner aspect of each thigh.
The slices in the middle and at the edge of the
primary beam field were taken into account when
the measurement planes were selected. In the scat-
tered beam area, measurements were recorded in
several successive slices adjacent to the primary
beam field. Thereafter, they were recorded in every
other slice, and the missing values were determined
by linear interpolation. This procedure yielded a
total of between 40 and 60 measuring points per
investigation.
Plastic pins with notches were used to position
two TLDs in holes in the phantom slice at each
measuring point. Superficial doses were measured by
placing the TLDs in small plastic bags and securing
them to the phantom with adhesive tape.
Positions of the organs in the phantom
The vertebral body in each slice was identified on
the basis of a CT scan of the Alderson phantom.
Since one-to-one allocation was not always possible,
several vertebral bodies or just parts of one vertebral
body were allocated to one slice, e.g. slice no. 22
contains a quarter of thoracic vertebral body T11
and a third of T12.
After the vertebral bodies were identified, the
organ masses were allocated to the slices on a pro
rata basis using the procedure described in ref. (3),
e.g. 25 % of the liver is located at the level of T11
and 17 % at T12. Accordingly, slice no. 22 contains
11.92 % of the liver.
The positions of the organs within a slice were
drawn with the aid of an anatomical atlas(4) and the
specimens in the anatomical collection of the
University of Zurich. They were then verified by an
experienced radiologist (see Figure 2 for an
example).
A position indicator was then assigned to each
organ, i.e. c for organs in a primarily central
location and p for organs that were represented pri-
marily by the peripheral measuring points. The
central organs (c) were the ovaries, bladder, oesopha-
gus and red bone marrow. All other organs were
assigned the peripheral position indicator (p).
The dose for the organs skin, bone surface and
‘remainder’ (other organs) was calculated on the
basis of the distribution across phantom slices
described in ref. (5). Uniform distribution across
slices 3–9 was assumed for the salivary glands and
across slices 0–6 for the brain.
Standardisation of the absorbed dose
Since the average absorbed dose in the primary
beam area was not always the same (even after the
automatic tube current modulation had been
switched off ) when measurements were taken with
and without protective equipment—despite the fact
that the investigations were identical, the exposure
settings were the same and the phantom was always
in the same position—the doses measured with and
without the protective equipment were converted to
the same primary beam field reference dose for ease
of comparison.
Calculation of the organ dose
First the resulting absorbed dose per measuring
point was determined for all investigations. This was
then divided by the number of acquired tomography
series in the investigation. The dose proportions in
the topogram accounted for by these doses were
accordingly assigned to the individual series of
tomographies.
In order to calculate the organ dose (equivalent
dose in an organ), for each slice the mean of the
peripheral measuring points ð MpÞ or the mean of
the central measuring points ð McÞ—depending on
the position indicator of an organ in each slice—was
weighted with the relative organ mass fi of the slice i
as a proportion of the total organ, and multiplied by
the beam-weighting factor wR for photons (¼1)
according to ICRP 103(6). The means of slices with
Figure 2. CT tomogram with organs and measuring points
drawn in.
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no measuring points were determined by inter-
polation from adjacent slices as follows:
Horgan slice i ¼ Mi;j  fi  wR; where j ¼ p or c:
The mean organ dose was calculated by adding
together the weighted dose proportions per slice for
each organ as follows:
Horgan ¼
X
slice i
Horgan slice i
The mean organ dose in the scattered beam area was
calculated by considering the proportions of the
organs located outside the primary beam field and
covered by the protective equipment separately. For
the purposes of this calculation, the proportion of
the mass of the organ parts covered by protection
was assumed to be 100 %.
Horgan scattered radiation ¼
X
slices
Ms;j  fs  wR;
where s ¼ slice in protective equipment area
and j ¼ p or c:
Protection factors
Two different protection factors were introduced.
The physical protection factor describes the protec-
tive effect at the individual measuring points as a
function of their position within the phantom slice
and as a function of the distance from the primary
beam field. It is calculated as follows from the
means of the measuring points in a slice i in the
scattered beam area:
PFphys i;j ¼ 1 
Mi;j with protective equipment
Mi;j without protective equipment
;
where j ¼ p or c:
The protective effect for the organs is described by
the organ-specific protection factor. This refers
exclusively to the proportions of organs that are
within the scattered beam area and covered by the
protective equipment. This effect is expressed as a
percentage as follows:
PForgan ¼
1 Horganscattered radiation;withprotective equipment
Horganscattered radiation;withoutprotective equipment
100%:
RESULTS
Within the scattered beam area, the measurements
from all the investigations show that protective
equipment reduces the overall dose. This applies at
measuring points on the periphery of the slices as
well as at the centrally located measuring points.
In the thoracic investigations performed with the
64-slice CT, there was a statistically significant dose
difference ( p , 0.001) in the means of the recorded
measuring points within a slice only from a distance
of 5 cm from the edge of the protective equipment
(edge of the lead). In the 16-slice CT for the thoracic
investigation a statistically significant difference was
perceptible from a distance of 2.5 cm from the edge
of the lead ( p , 0.001) and for the abdominal/pelvic
investigation from a distance of 7.5 cm ( p , 0.001),
whereas the differences for the brain investigation
were apparent right from the edge of the lead.
Physical protection factors
The protective equipment’s ability to reduce the dose
in the phantom during the investigations is illus-
trated in Figure 3, which shows the physical protec-
tion factor as a function of distance from the edge
of the lead.
The physical protection factor tends to be greater
at the periphery than at the centre and grows as the
measuring points’ distance from the edge of the lead
increases.
Organ-related results
Table 3 provides an overview of the position of the
organs in relation to the primary and scattered beam
areas. The measured mean equivalent dose in the
primary beam area is shown in Table 4 and was cal-
culated from the means of all measuring points of
the layers at the centre and at the edge of the
primary beam field. Table 5 illustrates the effect of
the protective equipment on the organs/organ parts
within the scattered beam area during the various
investigations. Only those parts of the organs
covered by the protective equipment are taken into
account. The absolute reduction in the mean organ
dose as a result of using protective equipment is
shown in Table 6.
DISCUSSION
The aim of this study was to determine the dosi-
metric data needed to evaluate whether, and if so
what, specific protective equipment is beneficial
during CT scans.
CT scans generate not only the primary radiation
that is essential for image acquisition, but also the
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Figure 3. Physical protection factors in the scattered beam area.
Table 3. Overview of organ distribution across primary and scattered beam areas.
Organ Organ proportion in primary beam area/organ proportion in scattered beam area
(total of 1)
Thorax 64S Thorax 16S Abdomen/pelvis 64S Brain 64S
Thyroid 1/0 1/0 0/1 0/1
Breast female 1/0 1/0 0/1 0/1
Breast male 1/0 1/0 0/1 0/1
Oesophagus 1/0 1/0 0.15/0.85 0/1
Lung 1/0 1/0 0.15/0.85 0/1
Stomach 1/0 1/0 0.65/0.35 0/1
Liver 0.93/0.07 0.97/0.03 0.82/0.18 0/1
Kidney 0.25/0.75 0.4/0.6 1/0 0/1
Colon 0.075/0.925 0.09/0.91 1/0 0/1
Small intestine 0.02/0.98 0.03/0.97 1/0 0/1
Ovaries 0/1 0/1 1/0 0/1
Bladder 0/1 0/1 1/0 0/1
Testes 0/1 0/1 0/1 0/1
Red bone marrow 0.465/0.535 0.48/0.52 0.61/0.39 0.09/0.91
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scattered radiation that represents additional
absorbed dose load for the body. This scattered radi-
ation can be subdivided into two categories. The
first is the internal scattered radiation, which is gen-
erated as a result of interactions between photons
and electrons along the body’s axis. The second is
the external scattered radiation, which is generated
by so-called overranging and by leakage of radiation
from the scanner. Overranging is the term applied to
the additional rotations beyond the start and end of
the imaged volume that are required to reconstruct
the tomogram. Radiation leakage refers to the radi-
ation that escapes from the tube housing. Superficial
protective equipment had no effect either on the
dose caused by the primary beam or on the internal
scattered radiation. However, it is capable of protect-
ing the body from the external scattered radiation to
a large extent.
Several aspects need to be considered when evalu-
ating the effectiveness of protective equipment. One
of the criteria employed was the ability of the
Table 4. Mean equivalent dose in the primary beam area.
Thorax 64S Thorax 16S Abdomen/pelvis 64S Brain 64S
9.03 mSv 10.88 mSv 20 mSv 47.96 mSv
Table 5. Overview of organ-specific protection factors in the scattered beam area.
Organs Mean organ dosea
in the scattered beam area without
protective equipment (mSv)
Mean organ dose in the
scattered beam area with
protective equipment (mSv)
PForgan (%)
Thorax on 64-slice CT
Kidney 1.40 1.10 22
Colon 0.77 0.56 27
Small intestine 0.45 0.29 35
Ovaries 0.14 0.09 40
Bladder 0.12 0.07 41
Testes 0.05 ,0.01 93
Red bone marrow 0.44 0.33 25
Thorax on 16-slice CT
Kidney 1.74 1.67 4
Colon 0.80 0.71 11
Small intestine 0.56 0.47 18
Ovaries 0.21 0.17 19
Bladder 0.17 0.14 18
Testes 0.06 0.01 76
Red bone marrow 1.52 1.44 5
Abdomen/pelvis on 64-slice CT
Thyroid 0.25 0.19 25
Breast femaleb 0.45 0.21 53
Breast male 2.62 2.48 5
Oesophagus 1.38 1.28 7
Lung 1.74 1.59 9
Testes 4.55 0.82c 82d
Red bone marrow 1.22 1.13 8
Brain on 64-slice CT
Thyroid 1.34 0.90 33
Breast female 0.25 0.02 91
Breast male 0.26 0.10 61
Oesophagus 0.43 0.24 44
Lung 0.32 0.15 54
Stomach 0.09 0.03 71
Liver 0.03 0.02 73
Kidney 0.03 ,0.01 84
Colon 0.02 ,0.01 84
Red bone marrow 0.25 0.16 36
aOrgan mass proportions in the protective equipment area¼100 %.
bCalculated from a separate measurement; see also Table 2.
cCalculated with protection factor for testicular capsules from ref. (7).
dProtection factor for testicular capsules from ref. (7).
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protective equipment to reduce the dose at a defined
point in the scattered beam area. The physical pro-
tection factor was introduced for this purpose. It
depends on the exposure parameters and on the gap
between the edge of the primary beam field and the
protective equipment (edge of the lead) and varies
according to the location of the respective measuring
point. Furthermore, organ size and position have a
significant impact on efforts to evaluate the protec-
tive effect for individual organs. The organ-specific
protection factor was defined for this purpose.
Finally, if one wants to quantitatively compare the
efficiency of protective equipment with other types
of radiation exposure in radiology, it is not sufficient
to simply consider the relative dose reduction. For
this reason, absolute dose reduction values were also
determined in this study, i.e. the mean organ dose
and the effective dose according to ICRP 103(6),
which takes into account the different radiation sen-
sitivities of the organs (Table 7).
These results show that using protective equipment
reduces radiation doses. In the interests of efficient
protection, it is obviously crucially important for the
protective equipment to be positioned as close as
possible to the primary beam field. The measure-
ments show that the dose can be reduced to a lesser
extent at the centre of the body than at the periphery,
i.e. those organs that are closer to the surface, e.g. the
thyroid, breasts or kidneys, benefit more from the use
of the protective equipment than central organs such
as the bladder or ovaries. This is explained by the fact
that the external scattered radiation that the
protective equipment can reduce is largely absorbed
as it penetrates the body and thus contributes less to
the dose at the centre of the body than at peripherally
located points. The protection factors also increase
with the distance of the measuring points to the
primary beam. This suggests that the internal scat-
tered radiation along the body’s axis declines faster
than the external scattered radiation in the air. Thus,
the organs that can best be protected are those
located far from the primary beam field, that tend to
lie near the surface and/or that protrude from the
trunk and thus present a smaller area of contact for
the internal radiation to penetrate. The surface of
such protruding organs can largely be covered by the
protective equipment, which will increase the protec-
tive effect. This particularly applies to the testes,
which can be almost entirely protected by testicular
capsules, and to the female breasts, which can be
covered by a wrap-around demi apron.
The observed protection factors differ from one
investigation to another performed on the same CT
scanner. Lower protection factors were found during
the abdominal/pelvic investigation than during the
other investigations. This is because the internal
scattered radiation is absorbed to a lesser extent by
the lungs than by the other soft tissues involved in
the other investigations by virtue of the lower
density of the lungs. The radiation thus penetrates
further along the body’s axis than during the other
investigations. In this investigation therefore, the
internal scattered radiation makes a greater contri-
bution to the dose received by organs located further
away from the primary beam. In brain investi-
gations, the geometry of the body has a positive
effect on the protection factors; the neck has a
reduced contact area for the internal scattered radi-
ation to penetrate. Covering the shoulders with pro-
tective equipment can also reduce exposure to
radiation emerging from the head.
The two thoracic investigations with the 64- and
16-slice CT showed differing protection factors. The
lower protection factors with the 16-slice CT are
Table 6. Absolute organ dose reduction in the scattered
beam area.
Organ Dose reduction (mSv)
Thorax
64S
Thorax
16S
Abdomen/pelvis
64S
Brain
64S
Thyroid — — 0.06 0.44
Breast female — — 0.24a 0.22
Breast male — — 0.14 0.16
Oesophagus — — 0.10 0.19
Lung — — 0.15 0.17
Stomach — — — 0.06
Liver — — — 0.06
Kidney 0.30 0.07 — 0.02
Colon 0.20 0.09 — 0.01
Small intestine 0.16 0.1 — ,0.01
Ovaries 0.06 0.04 — ,0.01
Bladder 0.05 0.03 — ,0.01
Testes 0.05 0.05 3.73b ,0.01
Red bone marrow 0.11 0.08 0.09 0.09
aCalculated from a separate measurement; see also Table 2.
bCalculated with the protection factor for testicular
capsules from ref. (7).
Table 7. Overview of effective doses.
Investigation Effective dose
without protective
equipment (mSv)
Effective
dose with
protective
equipment
(mSv)
Dose
reduction
(mSv)
Abdomen/pelvis
male
11.40 11.08 0.32
Abdomen/pelvis
female
12.31 12.27 0.04
Brain 1.91 1.81 0.11
Thorax 5.61 5.55 0.06
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very probably attributable to the lower radiation
leakage from this scanner.
Protective equipment proved most effective when
applied to the testes in the form of testicular cap-
sules (results of the measurements from ref. (7–9)).
The protection factor here is between 77 and 95 %.
The dose reduction is particularly impressive when
testicular capsules are used for abdominal/pelvic
investigations, because the primary beam passes very
close to the testes, and protection may even be pro-
vided for part of the dose caused by overranging.
This study also found noteworthy dose reductions
for the thyroid during the brain investigation (33 %)
and the female breast during the brain and abdomi-
nal/pelvic investigations (91 and 53 %, respectively).
This is relevant particularly because breast protec-
tion is rarely provided as a matter of routine in
Switzerland. Furthermore, thyroid protectors on
patients are only used routinely in isolated cases.
The effective dose for the individual investigations
was determined from the measurements. According
to ICRP 103(6), this is a suitable parameter for the
quantitative comparison of differing diagnostic
investigations. The overview in Table 7 shows that
the greatest reduction in the effective dose was
achieved in the abdominal/pelvic investigation of
men, primarily as a result of the protective effect of
the testicular capsules. For women, the reduction
largely arises as a result of protecting the breasts.
During the brain investigation, over half the
reduction in the effective dose was achieved by pro-
tecting the breasts, lungs and thyroid. For the thor-
acic investigation, around half of the dose reduction
was achieved by protecting the colon.
The relative reduction in the effective dose was very
low, amounting to 3 % for male and ,1 % for female
abdominal/pelvic investigation. The corresponding
figures for the brain and thoracic investigations were 5
and 1 %, respectively. The greatest contributions to the
effective dose obviously stemmed from the dose gener-
ated directly by the primary beam.
However, if the effective dose of a chest X-ray (PA)
of 0.06 mSv(10) is taken as a benchmark, the use of
protective equipment during abdominal/pelvic CT
scans produces, on an average by gender, an absolute
dose reduction approximately equivalent to the dose
exposure of three chest X-rays. For male patients, a
reduction of five chest X-ray equivalents can be
assumed and for female patients of less than one chest
X-ray; the corresponding reductions for brain and
thoracic CT scans are two chest X-rays and one chest
X-ray, respectively. This should be taken into account
when the effectiveness of protective equipment for CT
is evaluated. Of course all other efforts to reduce the
dose must be maintained and constantly improved.
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